Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA warns prenatal product marketer

This article was originally published in The Tan Sheet

Executive Summary

Pan American Labs' Neevo caplets prenatal product is misbranded as a "medical food" because it does not meet the statutory definition of such under FDA's Orphan Drug Act, FDA says in a Nov. 20 warning letter to firm President Eric M. Wingerter. Following a review of Neevo Web sites, which state the product is a medical food for women who are pregnant, planning to become pregnant or who are postpartum, the agency said that the caplets do not meet the definition because the nutritional requirements they provide can be met through a modified normal diet alone - unlike products defined as medical foods
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS103592

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel